Inovio Pharmaceuticals
INO
#9099
Rank
HK$0.92 B
Marketcap
HK$13.52
Share price
0.58%
Change (1 day)
-21.68%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.51. In 2024 the company made an earnings per share (EPS) of -HK$30.87 an increase over its 2023 EPS that were of -HK$47.59.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.29%
2024-HK$30.87-35.14%
2023-HK$47.59-56.62%
2022-HK$109.72-19.54%
2021-HK$136.3735.9%
2020-HK$100.34-11.57%
2019-HK$113.4715.24%
2018-HK$98.47-2.78%
2017-HK$101.286.93%
2016-HK$94.72134.88%
2015-HK$40.32-29.51%
2014-HK$57.20-57.34%
2013-HK$134.10146.55%
2012-HK$54.3920.83%
2011-HK$45.01-29.41%
2010-HK$63.77-48.48%
2009-HK$123.7910%
2008-HK$112.5311.11%
2007-HK$101.28-41.3%
2006-HK$172.55-66.91%
2005-HK$521.40110.61%
2004-HK$247.57-61.63%
2003-HK$645.19186.67%
2002-HK$225.07
2001N/A-100%
2000-HK$180.05-63.64%
1999-HK$495.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.04-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.52-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.63-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$50.95-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.10-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.45-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$9.77-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA